Exploring Public Biotech Stocks
Unlock biotech investment intel in Favorable Environments: Wassim Laroussi reveals trends like $32.1B Q4 2024 M&A (PitchBook, +20% YoY) signaling job-creating consolidations in oncology/obesity amid rising rates. From his IQVIA roots, he advises valuing companies as full acquisitions for policy-aligned funding decisions.
Listen and connect with USD Discovery District to leverage data for regional economic impact and compliant growth strategies.